Epidemiological risk assessment of countries concerning COVID-19, dated 16/1/2021
The epidemiological image of various countries with regard to the COVID-19 disease has been re-evaluated by the Epidemiological Monitoring and Control of Infectious Diseases Unit of the Medical Services and the Public Health Services. The evaluation was based on the epidemiological indicators of the countries, such as: the effective reproduction number R(t) for SARS-CoV-2, the number of new diagnoses, the number of laboratory tests, the mortality rate per 100,000 inhabitants, the estimated prevalence and the impact and classification by the World Health Organization (WHO), as these indicators appear on valid databases.
The following categorization of countries, based on the epidemiological risk assessment, is extremely dynamic and may be modified at any moment as the pandemic evolves and the epidemiological data change. For this reason, new data would be announced and the list of countries updated frequently.
It should be noted that in categorizing countries the recommendation of the European Council, dated 30 June, on the gradual and coordinated lifting of travel restrictions to the European Union has been taken into consideration.
Category A – Low risk countries at the current stage
Included in this category are countries with an effective reproduction (Rt) number lower than 1 or/and small number of new diagnoses (<1/100,000 inhabitants per day) or/and small or very small COVID-19 mortality (<5-10/100,000 inhabitants) or/and classification of sporadic cases or clusters of cases according to the WHO or/and at least satisfactory laboratory testing (>3000 tests/100,000 inhabitants).
It should be noted that passengers coming from Category A countries are not required to present a laboratory COVID-19 test certificate or go into self-isolation.
Category B - Countries with possibly low risk but greater uncertainty compared to Category A
Included in this category are countries with an effective reproduction (Rt) number greater than 1 or/and number of new diagnoses <1/100,000 inhabitants per day or/and increased COVID-19 mortality (>10/100,000 inhabitants) or/and limited laboratory testing (<2000 tests/100,000 inhabitants) or lack of WHO classification
It should be noted that passengers coming from Category B countries will be required to have undertaken a laboratory test within 72 hours prior to departure and to possess a Certificate showing negative PCR examination for the virus.
It is also clarified that passengers from Category B countries, falling into the following categories, may carry out the molecular examination upon arrival in the Republic:
a) Cypriot citizens and family members (alien spouses, underage children and parents thereof),
b) all those legally residing in the Republic,
c) persons entitled to under the Vienna Convention,
d) persons, irrespective of nationality, whose countries of residence do not provide a laboratory testing service (public or private), to those wishing to travel to the Republic of Cyprus and following a relevant announcement.
It should be noted that the examination cost will be borne by themselves and in addition, such persons should remain in self-isolation at home until the examination result is issued.
Category C – Increased risk countries compared to categories A and B
All countries not included in categories A or B are placed in this category. Some of the countries which are of high risk according to their epidemiological picture, are mentioned above.
In accordance with the Infectious Diseases Decree (No.2) of 2021, entry into the Republic from Category C countries shall be allowed only for specific categories of citizens who have the possibility to choose whether to undergo a diagnostic test for COVID-19 upon their arrival in Cyprus or have with them a negative RT-PCR test certificate for COVID-19, undertaken within 72 hours prior to departure. It is noted that such persons can either undergo a molecular examination for COVID-19 on the 10th day of their self-isolation, at their own expense, and have their self-isolation terminated provided that the outcome of the molecular examination is negative, or be released on the 14th day of self-isolation provided that they are not COVID-19 positive, according to the guidelines of the Ministry of Health.
It is underlined that all passengers, regardless of country category, shall be obliged to submit an application for the CyprusFlightPass within 24 hours prior to their departure flight. Moreover, in order to insure public health and the monitoring of the epidemiological situation, a sample molecular laboratory testing of passengers on selected arriving flights will be carried out.
It should be noted that the above categorization of countries shall take effect on 18 January 2021.
Relevant Press Releases
Health and Hospital Statistics 2020